mskcc.org13d
Imlunestrant Stops Progression of ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy
An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
mskcc.org4d
The Secret Life of ALAS1: How a Basic Science Discovery Could Pave the Way for Better siRNA Therapies
New research from Dr. Seungjae Lee, Dr. Eric Lai, and their collaborators points to a potential opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially ...
mskcc.org3d
A Guide for Adolescents and Young Adults (AYAs): Coming Out to Your Care Team
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org13d
Imlunestrant: A Promising Oral Therapy Option for Patients with ER+/HER2- Advanced Breast Cancer
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
mskcc.org11d
The Danwei Huangfu Lab
We apply both precision gene editing and large-scale CRISPR screening in human pluripotent stem cells (hPSCs) to explore mechanisms underlying human development. Specifically, we are interrogating the ...
mskcc.org13d
Tejus A. Bale, MD, PhD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org4d
Andrew R. Barsky, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org6d
Making Sure Your Sisters Are Treated Equally: New Insights Into Cohesin, Chromosome Dynamics and Genome Instability
Tea will be served at 12:45 p.m., immediately preceding the seminar.
mskcc.org11d
Lisa R. Allen, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org6d
Sree Bhavani Chalasani, MD
Research at MSK Our research impact Research topics Core facilities & resources ...